Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH) research hub

Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency

This study is testing a new medicine, deucrictibant, for adults with a rare swelling condition called acquired angioedema (AAE). It looks at whether the medicine can prevent swelling attacks and also treat them when they happen, compared to a dummy pill.